Medindia
Medindia LOGIN REGISTER
Advertisement

Gen-Probe to Webcast Presentation at Bank of America's 37th Annual Investment Conference

Thursday, September 13, 2007 General News
Advertisement
SAN DIEGO, Sept. 12 Gen-Probe Incorporated(Nasdaq: GPRO) announced today that the Company will present at Bank ofAmerica's 37th Annual Investment Conference in San Francisco on September 18,2007 at approximately 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). Thepresentation is scheduled to be webcast live and may be accessed through alink on the investor information section of Gen-Probe's website athttp://www.gen-probe.com. The webcast will be available for 30 days followingthe event.
Advertisement

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufactureand marketing of rapid, accurate and cost-effective nucleic acid tests (NATs)that are used primarily to diagnose human diseases and screen donated humanblood. Gen-Probe has more than 24 years of NAT expertise, and received the2004 National Medal of Technology, America's highest honor for technologicalinnovation, for developing NAT assays for blood screening. Gen-Probe isheadquartered in San Diego and employs approximately 1,000 people. For moreinformation, go to http://www.gen-probe.com.
Advertisement

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs,plans, objectives, assumptions or future events or performance are nothistorical facts and are forward-looking statements. Forward-lookingstatements are not guarantees of performance. They involve known and unknownrisks, uncertainties and assumptions that may cause actual results, levels ofactivity, performance or achievements to differ materially from thoseexpressed or implied by any forward-looking statement. For information aboutrisks and uncertainties we face and a discussion of our financial statementsand footnotes, see documents we have filed with the SEC, including the Form10-Q for the period ended June 30, 2007, and all subsequent periodic filingsmade with the SEC. We assume no obligation and expressly disclaim any duty toupdate any forward-looking statement to reflect events or circumstances afterthe date of this press release or to reflect the occurrence of unanticipatedevents.Contact: Paula Izidoro Investor Relations 858-410-8904

SOURCE Gen-Probe Incorporated
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close